News

Greek Life fosters renewed relationship with UACC

Members of the University of Arizona Pi Kappa Alpha (PIKE) fraternity and Alpha Chi Omega sorority recently met with UACC researchers in order to help re-establish the relationship between the two entities.

READ MORE

Fishing for Answers

Cancer researchers are constantly searching for innovative ways to develop life-saving therapies as quickly as possible. The possible key to unlocking these cures can be found at any pet store throughout the world.

READ MORE

Georg Wondrak, PhD, earns inaugural Director’s Challenge Award

Georg Wondrak, PhD, received the UA Cancer Center Director’s Challenge Award for Therapeutic Development.

READ MORE

UACC director meets with Phoenix mayor

Dr. Andrew S. Kraft recently discussed the role of the University of Arizona Cancer Center on the Phoenix Biomedical Campus with Phoenix Mayor Greg Stanton.

READ MORE

UACC scientist wins BTE grant for breast cancer research

Dr. Pavani Chalasani to study biomarkers that might predict therapeutic response for breast cancer patients.

READ MORE

UACC researchers awarded funding from American Cancer Society

University of Arizona Cancer Center researchers are working on a variety of cancer projects thanks to funding from the American Cancer Society.

READ MORE

Stacy Lauver joins UACC as finance chief

Stacy Lauver, CPA, has joined the University of Arizona Cancer Center as assistant director of finance, coming from Pima  Community College.

READ MORE

UA-discovered drug for skin disease approved for patients in Europe

A synthetic hormone developed by UA faculty that has been shown to offer relief for a rare skin disease has been approved for patients in Europe.

READ MORE

UACC and BIO5 researcher awarded $1.59 million NCI grant to study drug resistance in lymphoma tumor treatment

Jonathan H. Schatz, MD, was recently awarded a 5-year, $1.59 million grant from the National Cancer Institute (NCI) to study ways to effectively combat drug resistance when treating lymphoma — a study that may have wide-ranging impact when it comes to treating a variety of cancers.

UACC and BIO5 researcher awarded $1.59 million NCI grant to study drug resistance in lymphoma tumor treatment

UA Cancer Center among founding members of the Academic Breast Cancer Consortium

The consortium includes National Cancer Institute-designated cancer centers, and prominent cancer institutes and research organizations.

UA Cancer Center among founding members of the Academic Breast Cancer Consortium